drugset / Trial / NCT00988481

Topiramate Augmentation in Bulimia Nervosa Partial Responders

NCT00988481

NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to generate pilot data exploring the addition of an augmentation (additional) medication to patients suffering from bulimia nervosa who have responded but not had complete symptom resolution with a course of standard medication treatment.

Timeline

Start
2009-09
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 200 mg

Indications